PETALING JAYA: Ucrest Bhd
has been granted its first patent in Taiwan for its flagship product, an (AI)-powered digital health platform, iMedic™.
In a filing to Bursa Malaysia, the company said the patent signifies a major achievement in its intellectual property journey and reinforces its leadership in the global digital healthcare industry.
The platform, consisting of intelligent connectivity and secure data infrastructure, enables iMedic™ to deliver highly personalised healthcare, continuous monitoring, and predictive analytics for preventive care and chronic disease management.
The patent will protect UCrest's AI-powered diagnostics, personalised health analytics and remote patient management.
Moving forward, UCrest expects to file more patents as it expands the technological capabilities and applications of its iMedic™ platform.
